PATENT CLAIM ANALYSIS

Application Number: 15881060
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "269000"]

Abstract:
The invention relates to a product containing the compound of formula (I) below (I) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having PDE5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.

Claim (Index 20):
The method according to claim  1  wherein the compound having PDE5-inhibitory properties is sildenafil.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.52174
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12439290', '14335657', '14873787', '13058639', '14079548']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7196558020376478
- 35 USC 102 Novelty (BERT): 0.5673262856344122
- Combined Prediction Score: 0.7044228503973242
- Mean Citation Score: 257.971992
- Max Citation Score: 427.47092
- Similarity Product: 375.8536237747192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test